Side Effects of Treatment

by

QUESTION

What are the probable side effects / reaction of “Artemether with Lumefantrine” to a 4.5 years, 5ml syrup, 2 doses – 0 & 8 hours?

ANSWER

Artermeter with Lumefantrine is often sold under the brand name “Coartem” and is widely distributed in areas of high P. falciparum prevalence, and particularly where known resistance to chloroquine occurs.

Coartem is also the drug of choice for the Roll Back Malaria programme. A study of 1332 children, mainly in sub-Saharan Africa, revealed that few children experienced any side effects while taking Coartem, and of these, the vast majority of side effects were mild, did not prevent the child from continuing to take the medication, and were resolved.

The most common symptoms that were observed in children were pyrexia (fever), cough, vomiting, loss of appetite and headaches. Other, more clinically significant but also more rare, side effects which have been observed include tinnitus (ringing in the ears), blood disorders, problems sleeping, heart palpitations, mood swings, gastrointestinal upset, itchiness, back pain and vertigo.

ARCEVA for malaria

by

QUESTION:

Is ARCEVA a good vaccine for malaria?

ANSWER:

ARCEVA isn’t a vaccine for malaria, but it is a brand name of one type of medication used to treat the disease. It belongs to the group of drugs called artemisinin-based combination therapies (ACTs), which are recommended by the World Health Organisation to treat uncomplicated malaria caused by Plasmodium falciparum, the most dangerous form of malaria. ARCEVA specifically contains artemether combined with lumefantrine. It is very important to know that there is no effective vaccine against malaria that is currently available; many scientists and researchers are vigorously hunting for such a vaccine, knowing that this would radically decrease the number of cases of malaria worldwide.

Drugs to Treat Pregnant Woman with Malaria

by

QUESTION:

What are the drugs for a pregnant woman who has malaria for the first to third trimester?

ANSWER:

The treatment of malaria in pregnant women has become more challenging in recent years, as many types of malaria are developing resistance to the standard arsenal of drugs. In locations where the dominant form of malaria is still chloroquine-sensitive, chloroquine can be used safely throughout pregnancy.

However, given the high levels of chloroquine-resistance, other drug regimens may be required. Currently, first-line treatment options for uncomplicated malaria caused by Plasmodium falciparum (many strains of which are resistant to chloroquine), is quinine plus clindamycin (doxycycline is contraindicated in pregnant women). In the second and third trimesters, artesunate plus clindamycin can be administered, or the artemisinin-based combination therapy (ACT) commonly used in that region, although some of these combinations, particularly those containing artemether, have limited safety testing in pregnant women. In general, the paucity of controlled, randomized trials has posed a problem to creating safe and effective recommendations for the treatment of malaria in pregnant women.